Outcome of cefazolin prophylaxis for total knee arthroplasty at an institution with high prevalence of methicillin-resistant Staphylococcus aureus infection

International Journal of Infectious Diseases

Volumn 15, Issue 12, 2011, Pages

  Song, Kyoung Ho ^a,b   Kang, Yu Min ^a   Sin, Hye yun ^a   Yoon, Su Won ^a   Seo, Hye kyung ^a   Kwon, Seonheui ^a   Shin, Myoung jin ^a   Chang, Chong Bum ^a,b   Kim, Tae Kyun ^a,b   Kim, Hong Bin ^a,b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Cefazolin; Knee replacement arthroplasty; Prosthesis related infection; Staphylococcus; Surgical wound infection

Indexed keywords

CEFAZOLIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; NONHUMAN; POSTOPERATIVE INFECTION; PREVALENCE; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURGICAL SITE INFECTION; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME;

ACADEMIC MEDICAL CENTERS; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY, REPLACEMENT, KNEE; CEFAZOLIN; COHORT STUDIES; CROSS INFECTION; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 82455162433     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.09.009     Document Type: Article

References (14)

1. Anderson D.J., Kaye K.S., Classen D., Arias K.M., Podgorny K., Burstin H., et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S51-S61.
2. Kim E.S., Song J.S., Lee H.J., Choe P.G., Park K.H., Cho J.H., et al. A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. J Antimicrob Chemother 2007, 60:1108-1114.
3. Kim H.B., Jang H.C., Nam H.J., Lee Y.S., Kim B.S., Park W.B., et al. In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother 2004, 48:1124-1127.
4. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999, 20:250-278. quiz 79-80.
5. Consensus paper on the surveillance of surgical wound infections. The Society for Hospital Epidemiology of America; The Association for Practitioners in Infection Control; The Centers for Disease Control; The Surgical Infection Society. Infect Control Hosp Epidemiol 1992;13:599-605.
6. Culver D.H., Horan T.C., Gaynes R.P., Martone W.J., Jarvis W.R., Emori T.G., et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991, 91:152S-157S.
7. Kim E.S., Chang Y.J., Park Y.S., Kang J.H., Park S.Y., Kim J.Y., et al. Multicenter surgical site infections surveillance system report, 2007: in total hip and total knee arthroplasties and gastrectomies. Korean J Nosocomial Infect Control 2008, 13:32-41.
8. Edwards J.R., Peterson K.D., Mu Y., Banerjee S., Allen-Bridson K., Morrell G., et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009, 37:783-805.
9. Bolon M.K., Hooper D., Stevenson K.B., Greenbaum M., Olsen M.A., Herwaldt L., et al. Improved surveillance for surgical site infections after orthopedic implantation procedures: extending applications for automated data. Clin Infect Dis 2009, 48:1223-1229.
10. Huotari K., Lyytikainen O. Impact of postdischarge surveillance on the rate of surgical site infection after orthopedic surgery. Infect Control Hosp Epidemiol 2006, 27:1324-1329.
11. Huenger F., Schmachtenberg A., Haefner H., Zolldann D., Nowicki K., Wirtz D.C., et al. Evaluation of postdischarge surveillance of surgical site infections after total hip and knee arthroplasty. Am J Infect Control 2005, 33:455-462.
12. Babkin Y., Raveh D., Lifschitz M., Itzchaki M., Wiener-Well Y., Kopuit P., et al. Incidence and risk factors for surgical infection after total knee replacement. Scand J Infect Dis 2007, 39:890-895.
13. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002, 136:792-801.
14. Darouiche R.O., Wall M.J., Itani K.M., Otterson M.F., Webb A.L., Carrick M.M., et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010, 362:18-26.